Mayank Mamtani
Stock Analyst at B. Riley Securities
(4.62)
# 201
Out of 5,126 analysts
142
Total ratings
50.81%
Success rate
42.29%
Average return
Main Sectors:
Stocks Rated by Mayank Mamtani
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYTK Cytokinetics | Maintains: Buy | $90 → $108 | $62.34 | +73.24% | 6 | Jan 21, 2026 | |
| IRD Opus Genetics | Initiates: Buy | $9 | $3.01 | +199.00% | 1 | Dec 10, 2025 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $33 → $42 | $23.49 | +78.80% | 2 | Dec 1, 2025 | |
| ZYME Zymeworks | Reiterates: Buy | $30 → $40 | $22.72 | +76.06% | 2 | Nov 21, 2025 | |
| NUVB Nuvation Bio | Initiates: Buy | $12 | $5.70 | +110.53% | 1 | Nov 19, 2025 | |
| NVAX Novavax | Reiterates: Buy | $18 → $16 | $8.25 | +93.94% | 20 | Nov 10, 2025 | |
| HROW Harrow | Reiterates: Buy | $70 → $74 | $47.32 | +56.38% | 4 | Oct 1, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $460 → $560 | $477.60 | +17.25% | 13 | Sep 29, 2025 | |
| NKTR Nektar Therapeutics | Maintains: Buy | $85 → $105 | $36.81 | +185.25% | 3 | Sep 23, 2025 | |
| TGTX TG Therapeutics | Maintains: Buy | $53 → $55 | $28.86 | +90.58% | 14 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $20.48 | +36.72% | 1 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.41 | +353.51% | 1 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $4.87 | +269.61% | 10 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $1.62 | +208.64% | 2 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $1.81 | +66.20% | 2 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.5 → $2 | $0.59 | +236.52% | 6 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 → $20 | $11.45 | +74.75% | 3 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.70 | +76.47% | 2 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 → $35 | $21.08 | +66.03% | 2 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 → $38 | $64.52 | -41.10% | 7 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $109 → $96 | $28.44 | +237.55% | 2 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $1 → $1.5 | $1.06 | +41.51% | 3 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $140 | $8.49 | +1,549.00% | 1 | Oct 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $210 → $90 | $3.56 | +2,428.09% | 5 | Apr 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $160 | $2.94 | +5,342.18% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $11 → $5 | $1.75 | +185.71% | 3 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $58 → $44 | $2.03 | +2,067.49% | 4 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $90 | $3.27 | +2,652.29% | 4 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $7 | $1.51 | +363.58% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9,750 → $4,500 | $0.79 | +571,546.34% | 3 | Jan 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5,000 → $2,700 | $1.13 | +238,838.05% | 2 | Nov 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $138 → $77 | $7.57 | +917.17% | 2 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $1,980 → $1,440 | $0.66 | +216,800.14% | 3 | May 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $2.80 | +42.86% | 2 | Apr 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $39 | $85.25 | -54.25% | 2 | Mar 18, 2020 |
Cytokinetics
Jan 21, 2026
Maintains: Buy
Price Target: $90 → $108
Current: $62.34
Upside: +73.24%
Opus Genetics
Dec 10, 2025
Initiates: Buy
Price Target: $9
Current: $3.01
Upside: +199.00%
Centessa Pharmaceuticals
Dec 1, 2025
Maintains: Buy
Price Target: $33 → $42
Current: $23.49
Upside: +78.80%
Zymeworks
Nov 21, 2025
Reiterates: Buy
Price Target: $30 → $40
Current: $22.72
Upside: +76.06%
Nuvation Bio
Nov 19, 2025
Initiates: Buy
Price Target: $12
Current: $5.70
Upside: +110.53%
Novavax
Nov 10, 2025
Reiterates: Buy
Price Target: $18 → $16
Current: $8.25
Upside: +93.94%
Harrow
Oct 1, 2025
Reiterates: Buy
Price Target: $70 → $74
Current: $47.32
Upside: +56.38%
Madrigal Pharmaceuticals
Sep 29, 2025
Maintains: Buy
Price Target: $460 → $560
Current: $477.60
Upside: +17.25%
Nektar Therapeutics
Sep 23, 2025
Maintains: Buy
Price Target: $85 → $105
Current: $36.81
Upside: +185.25%
TG Therapeutics
Sep 17, 2025
Maintains: Buy
Price Target: $53 → $55
Current: $28.86
Upside: +90.58%
Sep 12, 2025
Initiates: Buy
Price Target: $28
Current: $20.48
Upside: +36.72%
Aug 26, 2025
Initiates: Buy
Price Target: $20
Current: $4.41
Upside: +353.51%
Aug 13, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $4.87
Upside: +269.61%
Jun 16, 2025
Maintains: Buy
Price Target: $6 → $5
Current: $1.62
Upside: +208.64%
May 20, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $1.81
Upside: +66.20%
Mar 27, 2025
Maintains: Buy
Price Target: $2.5 → $2
Current: $0.59
Upside: +236.52%
Mar 19, 2025
Reiterates: Buy
Price Target: $11 → $20
Current: $11.45
Upside: +74.75%
Mar 14, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.70
Upside: +76.47%
Mar 5, 2025
Reiterates: Buy
Price Target: $38 → $35
Current: $21.08
Upside: +66.03%
Feb 14, 2025
Reiterates: Buy
Price Target: $51 → $38
Current: $64.52
Upside: -41.10%
Feb 7, 2025
Reiterates: Buy
Price Target: $109 → $96
Current: $28.44
Upside: +237.55%
Dec 19, 2024
Upgrades: Buy
Price Target: $1 → $1.5
Current: $1.06
Upside: +41.51%
Oct 13, 2023
Initiates: Buy
Price Target: $140
Current: $8.49
Upside: +1,549.00%
Apr 10, 2023
Maintains: Buy
Price Target: $210 → $90
Current: $3.56
Upside: +2,428.09%
Mar 29, 2023
Reiterates: Buy
Price Target: $160
Current: $2.94
Upside: +5,342.18%
Aug 19, 2022
Downgrades: Neutral
Price Target: $11 → $5
Current: $1.75
Upside: +185.71%
Aug 11, 2022
Maintains: Buy
Price Target: $58 → $44
Current: $2.03
Upside: +2,067.49%
Jul 14, 2022
Maintains: Buy
Price Target: $120 → $90
Current: $3.27
Upside: +2,652.29%
May 24, 2022
Downgrades: Neutral
Price Target: $14 → $7
Current: $1.51
Upside: +363.58%
Jan 24, 2022
Maintains: Buy
Price Target: $9,750 → $4,500
Current: $0.79
Upside: +571,546.34%
Nov 30, 2021
Maintains: Buy
Price Target: $5,000 → $2,700
Current: $1.13
Upside: +238,838.05%
Jan 15, 2021
Downgrades: Neutral
Price Target: $138 → $77
Current: $7.57
Upside: +917.17%
May 22, 2020
Downgrades: Neutral
Price Target: $1,980 → $1,440
Current: $0.66
Upside: +216,800.14%
Apr 3, 2020
Maintains: Buy
Price Target: $8 → $4
Current: $2.80
Upside: +42.86%
Mar 18, 2020
Maintains: Buy
Price Target: $47 → $39
Current: $85.25
Upside: -54.25%